Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/AYALA PHARMACEUTICALS INC/ 10-K

Annual Report · 10-K

AYALA PHARMACEUTICALS INC

ADXSNASDAQEQUITYCurrent

Annual Report

Filed Jan 22, 2021Accepted Jan 22, 2021, 11:38 AM ESTCIK 1100397Accession 0001493152-21-001656
View company →Permanent SEC source ↗
Share

Company context

Current securities

ADXSNASDAQ · EQUITY · Current
Historical securities (1)
ADXSWNASDAQ · WARRANT · Historical · closed Oct 19, 2018

Recent company filings

  1. SCHEDULE 13G - filed by Ayala Pharmaceuticals, Inc. regarding OS Therapies IncApr 16, 2025
  2. 15-12G filingMay 9, 2024
  3. 10-K/A filingApr 26, 2024
  4. 8-K/A filingApr 19, 2024
  5. 10-K filingApr 16, 2024

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗